Enzene Biosciences has raised $ 50 million to improve its manufacturing capability in order to provide affordable, high-quality medicines that save lives. ... Jan 31
Phylagen recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Testâ„¢ that detects SARS-CoV-2 in any built environment.... Dec 24
Hyundai Bioscience announced that CNPharm, its major shareholding biotech company, has succeeded in developing 'Poly-COV01,' an injection drug for the potential treatment of patients ... Dec 23
BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
Polaryx Therapeutics, today announced that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug Designations ... Dec 18
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in ... Dec 18
-Advertisements-